KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $19.7 million.

  • Pacira BioSciences' Interest & Investment Income rose 55.67% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 48.03%. This contributed to the annual value of $19.7 million for FY2024, which is 72.05% up from last year.
  • Per Pacira BioSciences' latest filing, its Interest & Investment Income stood at $19.7 million for FY2024, which was up 72.05% from $11.4 million recorded in FY2023.
  • Pacira BioSciences' Interest & Investment Income's 5-year high stood at $19.7 million during FY2024, with a 5-year trough of $896,000 in FY2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $11.4 million (2023), whereas its average is $11.9 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 80.64% in 2021, then spiked by 406.92% in 2022.
  • Yearly analysis of 5 years shows Pacira BioSciences' Interest & Investment Income stood at $4.6 million in 2020, then tumbled by 80.64% to $896,000 in 2021, then spiked by 406.92% to $4.5 million in 2022, then skyrocketed by 151.96% to $11.4 million in 2023, then surged by 72.05% to $19.7 million in 2024.